Daniel M Junius - Net Worth and Insider Trading
Daniel M Junius Net Worth
The estimated net worth of Daniel M Junius is at least $7 Million dollars as of 2025-04-26. Daniel M Junius is the Director of Immunogen Inc and owns about 184,987 shares of Immunogen Inc (IMGN) stock worth over $6 Million. Daniel M Junius is the Director of IDEXX Laboratories Inc and owns about 2,982 shares of IDEXX Laboratories Inc (IDXX) stock worth over $1 Million. Daniel M Junius is also the Director of GlycoMimetics Inc and owns about 93,250 shares of GlycoMimetics Inc (GLYC) stock worth over $24,338. Details can be seen in Daniel M Junius's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel M Junius has not made any transactions after 2023-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Daniel M Junius
Daniel M Junius Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel M Junius owns 4 companies in total, including IDEXX Laboratories Inc (IDXX) , GlycoMimetics Inc (GLYC) , and Immunogen Inc (IMGN) among others .
Click here to see the complete history of Daniel M Junius’s form 4 insider trades.
Insider Ownership Summary of Daniel M Junius
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
IDXX | IDEXX Laboratories Inc | 2023-04-28 | director |
GLYC | GlycoMimetics Inc | 2023-05-10 | director |
IMGN | Immunogen Inc | 2018-03-16 | Chief Financial Officer |
![]() | ![]() | 2016-10-25 | director |
Daniel M Junius Latest Holdings Summary
Daniel M Junius currently owns a total of 3 stocks. Among these stocks, Daniel M Junius owns 184,987 shares of Immunogen Inc (IMGN) as of March 16, 2018, with a value of $6 Million and a weighting of 81.3%. Daniel M Junius owns 2,982 shares of IDEXX Laboratories Inc (IDXX) as of February 16, 2023, with a value of $1 Million and a weighting of 18.36%. Daniel M Junius also owns 93,250 shares of GlycoMimetics Inc (GLYC) as of May 10, 2023, with a value of $24,338 and a weighting of 0.34%.
Latest Holdings of Daniel M Junius
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMGN | Immunogen Inc | 2018-03-16 | 184,987 | 31.23 | 5,777,144 |
IDXX | IDEXX Laboratories Inc | 2023-02-16 | 2,982 | 437.44 | 1,304,446 |
GLYC | GlycoMimetics Inc | 2023-05-10 | 93,250 | 0.26 | 24,338 |
Holding Weightings of Daniel M Junius
Daniel M Junius Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel M Junius has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the sale of 25,000 shares on March 16, 2018, which brought Daniel M Junius around $300,500.
According to the SEC Form 4 filings, Daniel M Junius has made a total of 6 transactions in IDEXX Laboratories Inc (IDXX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in IDEXX Laboratories Inc is the sale of 2,187 shares on February 16, 2023, which brought Daniel M Junius around $1 Million.
According to the SEC Form 4 filings, Daniel M Junius has made a total of 2 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 30,000 shares on May 10, 2023, which cost Daniel M Junius around $46,800.
Insider Trading History of Daniel M Junius
- 1
Daniel M Junius Trading Performance
GuruFocus tracks the stock performance after each of Daniel M Junius's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel M Junius is 12.14%. GuruFocus also compares Daniel M Junius's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel M Junius within 3 months outperforms 6 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel M Junius's insider trading performs compared to the benchmark.
Performance of Daniel M Junius
Daniel M Junius Ownership Network
Ownership Network List of Daniel M Junius
Ownership Network Relation of Daniel M Junius

Daniel M Junius Owned Company Details
What does IDEXX Laboratories Inc do?
Who are the key executives at IDEXX Laboratories Inc?
Daniel M Junius is the director of IDEXX Laboratories Inc. Other key executives at IDEXX Laboratories Inc include CORPORATE VICE PRESIDENT George Fennell , Corporate Vice President James F Polewaczyk , and director & President and CEO Jonathan Jay Mazelsky .
IDEXX Laboratories Inc (IDXX) Insider Trades Summary
Over the past 18 months, Daniel M Junius made no insider transaction in IDEXX Laboratories Inc (IDXX). Other recent insider transactions involving IDEXX Laboratories Inc (IDXX) include a net sale of 19,740 shares made by James F Polewaczyk , a net sale of 19,128 shares made by Jonathan Jay Mazelsky , and a net sale of 18,184 shares made by George Fennell .
In summary, during the past 3 months, insiders sold 12,986 shares of IDEXX Laboratories Inc (IDXX) in total and bought 0 shares, with a net sale of 12,986 shares. During the past 18 months, 85,826 shares of IDEXX Laboratories Inc (IDXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 85,826 shares.
IDEXX Laboratories Inc (IDXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEXX Laboratories Inc Insider Transactions
Daniel M Junius Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel M Junius. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Daniel M Junius's mailing address is: Waltham Ma 02451.